Defoamer 101/ Defoamer 102/ Defoamer 103
Product Name | Defoamer 101/ Defoamer 102/ Defoamer 103 |
Types | General reagent |
Storage | RT |
Synonyms |
Liquid preservative MB-1(instead of sodium azide, ProCli*300) - BMB0011 |
Defoamer 101 (Silicone defoamer)
Core advantages: high temperature resistance, fast defoaming, compatible with high shear process.
Recommended application:
PCR premixes/reagents: withstand 95℃ high temperature cycle, inhibit bubble interference in DNA polymerase reaction.
Chemiluminescent reagents: to avoid the foam in the luminous reaction to affect the light signal acquisition (such as acridol system).
Automated liquid handling systems: for rapid defoaming in sample needles or pipelines (such as automatic chemiluminescence meters).
Usage:
Starting recommendation: 0.01%-0.02% (w/v), adjusted according to the severity of the bubble, up to 0.05%.
Precautions: Need to pre-disperse (such as ultrasonic treatment) to avoid silicone oil accumulation; Avoid using with cationic surfactants.
Defoamer 102 (polyether modified silicone oil)
Core advantages: Self-emulsification, low residue, excellent biocompatibility.
Recommended application:
High sensitivity immunoassay (e.g. ELISA, fluorescent immunoassay) : Avoid defoamer residues interfering with antigen-antibody binding or fluorescent background.
Cell lysate: Inhibits the foam produced by nucleic acid/protein release during lysate, while protecting enzyme activity (e.g., protease K).
Microfluidic chip reagents: compatible with microchannel fluids to prevent bubble clogging.
Usage:
Starting recommendation: 0.005%-0.01% (w/v), ultra-low concentration can be effective, excessive may lead to turbidity of the system.
Note: Compatibility with phosphate buffers (PBS) is good, but high concentrations of calcium/magnesium ions should be avoided.
Defoamer 103 (nonionic surfactant (polyether))
Core advantages: low cost, low temperature stability, protection of biological macromolecules.
Recommended application:
Enzyme reaction reagents (such as ALT/AST biochemical detection) : reduce enzymatic denaturation at the liquid-gas interface and maintain reaction linearity.
Lyophilized reagent protectants: Inhibit foam during lyophilization/resolution while stabilizing protein structure.
Blood treatment reagents: prevent foam interference during hemolysis or centrifugation (such as serum separation glue).
Usage:
Starting recommendation: 0.05%-0.1% (w/v), can be adjusted according to the system viscosity (high viscosity requires higher concentration).
Note: Avoid using in hydrophobic protein systems (may form micellar adsorbed proteins).
SKU | UNIT | PRICE (USD) | QTY |
---|---|---|---|
BLDD101 | 100g | 46.7 | |
BLDD102 | 100g | 50 | |
BLDD103 | 100g | 46.7 |